Clinical pharmacogenetics implementation: approaches, successes, and challenges - Wikidata - wikimedia - TriplyDB

Clinical pharmacogenetics implementation: approaches, successes, and challenges

Clinical pharmacogenetics implementation: approaches, successes, and challenges

http://www.wikidata.org/entity/Q33825186

about

The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19 Pharmacogenomics of hypertension and heart disease Use of contemporary genetics in cardiovascular diagnosis Challenges to integrating pharmacogenetic testing into medication therapy management Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available Practical considerations in genomic decision support: The eMERGE experience Extracting research-quality phenotypes from electronic health records to support precision medicine Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting.Effects of Using Personal Genotype Data on Student Learning and Attitudes in a Pharmacogenomics Course Comparison of 2 models for gene-environment interactions: an example of simulated gene-medication interactions on systolic blood pressure in family-based data.An inter-professional approach to personalized medicine education: one institution's experience Emerging roles for pharmacists in clinical implementation of pharmacogenomics Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs.Pharmacogenomics in cardiology--genetics and drug response: 10 years of progress.The IGNITE network: a model for genomic medicine implementation and research.Pharmacogenomically actionable medications in a safety net health care system.Integrating electronic health record genotype and phenotype datasets to transform patient care Hypertension and aging.Hypertension pharmacogenomics: in search of personalized treatment approaches Cardiovascular Pharmacogenomics--Implications for Patients With CKD.The Outlier in All of Us: Why Implementing Pharmacogenomics Could Matter for Everyone.Physician response to implementation of genotype-tailored antiplatelet therapy.Other side of the coin for personalised medicine and healthcare: content analysis of 'personalised' practices in the literature CSER and eMERGE: current and potential state of the display of genetic information in the electronic health record.Implementing Pharmacogenomics at Your Institution: Establishment and Overcoming Implementation Challenges.Assessing the capability of massively parallel sequencing for opportunistic pharmacogenetic screening.Evidence for extensive pleiotropy among pharmacogenes.Multidisciplinary model to implement pharmacogenomics at the point of care.Institutional profile: University of Florida Health Personalized Medicine Program.Role of Genetic Testing in Patients undergoing Percutaneous Coronary Intervention.Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology.Personalizing antiplatelet prescribing using genetics for patients undergoing percutaneous coronary intervention.Commentary: Should Pharmacogenomic Evidence Be Considered in Clinical Decision Making? Focus on Select Cardiovascular Drugs.Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness research Navigating pleiotropy in precision medicine: pharmacogenes from trauma to behavioral health.Clopidogrel pharmacogenetics: from evidence to implementation.The influence of VKORC1 and CYP2C9 mutations on warfarin response after total hip and knee arthroplasty.Integrating pharmacogenomics into electronic health records with clinical decision support.Pharmacogenomics competencies in pharmacy practice: A blueprint for change.Collaborative Counseling Considerations for Pharmacogenomic Tests.

P2860

Q26801867-98EE32F1-4747-4BBA-807E-F3CDD6607700 Q27015722-644116D3-A20D-4049-AB2E-36A3156E334A Q27025306-87544F7D-E12F-4764-BD3E-CE68C2F8C5F7 Q28082835-40AA7538-C772-4CB4-83AC-3EE6D4131762 Q28552832-00F38CA8-2023-451E-8D23-27008471F3CF Q28608217-5348D415-B89A-4DF0-B115-CAAB47F935D7 Q28648163-25CE2B10-DF2D-4B72-8396-59118A7176A4 Q30612258-AF5FC7ED-C8C6-486C-9208-4820FEB18A66 Q31137602-3E545414-F986-4C7D-A96E-DB138FF599CF Q31149288-753A25E8-CA76-4B2A-9C8B-4E9787B00B7B Q33565033-5FAF3B5C-751F-4039-9F82-0886F5F941CB Q34302434-B5261818-4D8E-411E-B567-593DE33A11DA Q35762508-198E221E-0DF3-4D8E-99F6-12C7F839BE41 Q35769279-ECC6F4C7-0BB6-41CF-8B2F-763DF8C74510 Q35884676-7BA69C8F-9275-4E43-B979-1E4F19AFD2E5 Q36495808-96100D87-4180-4139-A08D-8B839D6EEE7F Q36599112-98352E3C-E71C-4717-AAE7-039228B9926B Q36623143-2E411F8B-D6C7-479D-9857-82483BDCA033 Q36652960-D9CEF6B0-C4D8-4175-BFC0-23E95509F3A2 Q36696635-6DCA5807-F0BF-421E-B703-B50434F566FD Q36794572-232F28AD-2A49-4D0B-BF30-C2DD89426EEA Q36984543-3CF10B5A-2B55-4706-8D22-F116655B1963 Q37100793-1F42460A-CC83-44C6-80B0-62E02986EAAE Q37229202-9FBB4A34-6FE4-43F9-BDE7-2E484DD9B7C8 Q37433329-C5A0DADA-7AE6-4603-BC21-93CB4C405E1F Q37651303-873ABF24-3D31-4376-B3FC-FAB7E58A1359 Q37703583-E957DA03-1A4D-49A9-A97C-A35BC70C5644 Q37716307-EC16E01F-9F6F-4491-AC94-E1CF77554DF3 Q38371889-7FA7A8EE-435A-480C-A0E2-57C876C5FE04 Q38401281-7AE907A8-8DFE-4519-A5E7-E3C5368F59E2 Q38655838-39020E41-E8DF-4268-B029-64A46FD633D4 Q38682772-3FEF8656-16A5-48BD-BEB4-EBB612763DE6 Q38707185-05DBB8FC-F822-40C5-B926-73114159E610 Q38730837-7E2E2538-6D81-493F-8FE0-A332E143D175 Q38792475-3AAC84E8-26B4-4EAD-A78E-0C9608E45207 Q38830015-C81FFCFC-6FD0-41E4-96CC-8479126CADED Q39124661-7D7154CF-EC9A-4743-9EE4-D5B0CC56EBFA Q39173300-D8D3227F-4B78-4D36-B240-3F0BB63B0869 Q39212511-D92B6FEF-9165-492E-B96E-A2A1C53C7AF5 Q39411218-AD3DC91E-6AFC-4209-B96C-C64B9DAC8F44

P2860

Clinical pharmacogenetics implementation: approaches, successes, and challenges

http://www.wikidata.org/entity/Q33825186

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Clinical pharmacogenetics implementation: approaches, successes, and challenges

@ast

Clinical pharmacogenetics implementation: approaches, successes, and challenges

@en

type

label

Clinical pharmacogenetics implementation: approaches, successes, and challenges

@ast

Clinical pharmacogenetics implementation: approaches, successes, and challenges

@en

prefLabel

Clinical pharmacogenetics implementation: approaches, successes, and challenges

@ast

Clinical pharmacogenetics implementation: approaches, successes, and challenges

@en

P1433

Q33825186-61907EA8-EDE6-4B8E-9E32-72B8572CB770

P1476

Q33825186-2C86F0E8-E2EC-4327-A369-23142CDE7316

P2093

Q33825186-290A7771-C50A-4817-94F3-33140B308B19

Q33825186-469AD064-2F7E-4A0F-A368-DA5181D18754

Q33825186-4CB89FEC-0457-49AD-891A-014BC58E8BAD

Q33825186-4EC98E49-21AF-489A-AF5D-11CE5B0B6DB4

Q33825186-555085A6-B057-44F0-B6D0-A8FDFD6B2314

Q33825186-59E2F085-B524-4A57-8B7F-19CC2F59408B

Q33825186-64A35D94-D9FC-42B5-B720-14B7B2CC3141

Q33825186-6B7EA8B7-635C-479E-85B0-AC92E8DF7415

Q33825186-7936AC17-117F-4D3D-8E5B-43A380B28621

Q33825186-7C93E44C-1749-4E67-A521-36282C7CB32D

P2860

Q33825186-00D3465A-75AD-4894-B4ED-F17411F9159D

Q33825186-0F590389-C7FD-4EC6-9AD7-2F34EF2EF2E7

Q33825186-128A6AB5-D446-4232-B5DC-95899D4DAC61

Q33825186-1EEA171E-8ABD-4274-9339-5BA8E2B77A17

Q33825186-2811A243-AC23-4376-9CE0-15472CDD92D8

Q33825186-448F7DDA-BBAD-4219-A833-17524DA33CC2

Q33825186-7C2EFB85-6E36-441D-90AA-280005662C56

Q33825186-88E7F3B9-7A86-47A9-AF62-AFCD84C378B6

Q33825186-B6AF2658-17A8-46DF-9E94-3EF5C0A41335

Q33825186-BC08E5B7-EB11-4303-A9F5-A3072FEEB765

P304

Q33825186-6D303185-E7AD-4146-9794-EEE3416E7A4E

P31

Q33825186-0376DCDD-1FC2-4071-A1F9-5FE1AA620607

P356

Q33825186-2F3B3295-1FFA-447E-B8DC-E50153861300

P433

Q33825186-28D66949-8F60-4512-B6D1-1C61F30A58E2

P478

Q33825186-963E860A-4BEE-4B9A-AA55-16E51725F299

P50

Q33825186-0F9D05C4-4D7E-46F6-88E2-6ECC4701754A

P577

Q33825186-118AFA7D-A305-405C-8ED6-81F2632345EB

P698

Q33825186-928C3F1C-3F03-4C4D-93B2-16805E3135B3

P932

Q33825186-F267E961-CC10-4E8C-A924-CA1078573F5D

P356

P1433

American Journal of Medical Genetics Part C: Seminars in Medical Genetics

P1476

Clinical pharmacogenetics implementation: approaches, successes, and challenges

@en

P2093

Amanda R Elsey

http://www.w3.org/2001/XMLSchema#string

Aniwaa Owusu Obeng

http://www.w3.org/2001/XMLSchema#string

Benjamin Burkley

http://www.w3.org/2001/XMLSchema#string

Benjamin J Staley

http://www.w3.org/2001/XMLSchema#string

David R Nelson

http://www.w3.org/2001/XMLSchema#string

David R Nessl

http://www.w3.org/2001/XMLSchema#string

Hui-Jia Dong

http://www.w3.org/2001/XMLSchema#string

J Felix Liu

http://www.w3.org/2001/XMLSchema#string

Julie A Johnson

http://www.w3.org/2001/XMLSchema#string

Kristin W Weitzel

http://www.w3.org/2001/XMLSchema#string

P2860

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

Pharmacogenomics and individualized medicine: translating science into practice.

Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.

Cytochrome p-450 polymorphisms and response to clopidogrel.

Genomics and drug response.

Clopidogrel: a case for indication-specific pharmacogenetics.

Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array.

Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.

Cost-effectiveness of cytochrome P450 2C19 genotype screening for selection of antiplatelet therapy with clopidogrel or prasugrel.

Challenges in implementing genomic medicine: the Mayo Clinic Center for Individualized Medicine.

P304

56-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJMG.C.31390

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

166C

http://www.w3.org/2001/XMLSchema#string

P50

R David Anderson

P577

2014-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24616371

http://www.w3.org/2001/XMLSchema#string

P932

4076109

http://www.w3.org/2001/XMLSchema#string